Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC Activation-Reference-Cited by-同舟云学术

Natural Product Vibsanin A Induces Differentiation of Myeloid Leukemia Cells through PKC Activation

Published:2016-03-16 Issue:9 Volume:76 Page:2698-2709
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Yu Zu-Yin,Xiao He,Wang Li-Mei,Shen Xing,Jing Yu,Wang Lin,Sun Wen-Feng,Zhang Yan-Feng,Cui Yu,Shan Ya-Jun,Zhou Wen-Bing,Xing Shuang,Xiong Guo-Lin,Liu Xiao-Lan,Dong Bo,Feng Jian-Nan,Wang Li-Sheng,Luo Qing-Liang,Zhao Qin-Shi,Cong Yu-Wen

Funder

Nature Science Foundation of China

Chinese Science and Technology

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

2. Analysis of binding mode of vibsanin A with protein kinase C C1 domains: An experimental and molecular dynamics simulation study;Journal of Molecular Structure;2022-07

3. The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification;Frontiers in Pharmacology;2022-04-27

4. The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells;Frontiers in Oncology;2022-04-12

5. PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer;Cancer Letters;2022-04